165 related articles for article (PubMed ID: 25367395)
1. Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugs.
Johnstone TC; Alexander SM; Wilson JJ; Lippard SJ
Dalton Trans; 2015 Jan; 44(1):119-29. PubMed ID: 25367395
[TBL] [Abstract][Full Text] [Related]
2. Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity.
Xu Z; Wang Z; Yiu SM; Zhu G
Dalton Trans; 2015 Dec; 44(46):19918-26. PubMed ID: 26514681
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride.
Xu Z; Chan HM; Li C; Wang Z; Tse MK; Tong Z; Zhu G
Inorg Chem; 2018 Jul; 57(14):8227-8235. PubMed ID: 29943979
[TBL] [Abstract][Full Text] [Related]
4. Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES).
Hall MD; Daly HL; Zhang JZ; Zhang M; Alderden RA; Pursche D; Foran GJ; Hambley TW
Metallomics; 2012 Jun; 4(6):568-75. PubMed ID: 22569908
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.
Ravera M; Gabano E; Zanellato I; Fregonese F; Pelosi G; Platts JA; Osella D
Dalton Trans; 2016 Mar; 45(12):5300-9. PubMed ID: 26903367
[TBL] [Abstract][Full Text] [Related]
6. Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.
Varbanov HP; Valiahdi SM; Kowol CR; Jakupec MA; Galanski MS; Keppler BK
Dalton Trans; 2012 Dec; 41(47):14404-14415. PubMed ID: 22886297
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformations.
Song Y; Suntharalingam K; Yeung JS; Royzen M; Lippard SJ
Bioconjug Chem; 2013 Oct; 24(10):1733-40. PubMed ID: 23957697
[TBL] [Abstract][Full Text] [Related]
8. Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex.
Pelosi G; Ravera M; Gabano E; Fregonese F; Osella D
Chem Commun (Camb); 2015 May; 51(38):8051-3. PubMed ID: 25865106
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Structures of 9-Oxabispidine Analogues of Cisplatin, Carboplatin, and Oxaliplatin.
Pollak D; Goddard R; Pörschke KR
Inorg Chem; 2016 Sep; 55(18):9424-35. PubMed ID: 27603202
[TBL] [Abstract][Full Text] [Related]
10. BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity.
Yao H; Chen S; Deng Z; Tse MK; Matsuda Y; Zhu G
Inorg Chem; 2020 Aug; 59(16):11823-11833. PubMed ID: 32799491
[TBL] [Abstract][Full Text] [Related]
11. Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark Toxicity.
Spector D; Bubley A; Zharova A; Bykusov V; Skvortsov D; Ipatova D; Erofeev A; Gorelkin P; Vaneev A; Mazur D; Nikitina V; Melnikov M; Pergushov V; Bunin D; Kuzmin V; Kostyukov A; Egorov A; Beloglazkina E; Akasov R; Krasnovskaya O
ACS Appl Bio Mater; 2024 May; 7(5):3431-3440. PubMed ID: 38697834
[TBL] [Abstract][Full Text] [Related]
12. Antitumor Platinium(IV) Prodrugs: A Systematic Computational Exploration of Their Reduction Mechanism by l-Ascorbic Acid.
Dabbish E; Ponte F; Russo N; Sicilia E
Inorg Chem; 2019 Mar; 58(6):3851-3860. PubMed ID: 30843385
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine.
Harringer S; Hejl M; Enyedy ÉA; Jakupec MA; Galanski MS; Keppler BK; Dyson PJ; Varbanov HP
Dalton Trans; 2021 Jun; 50(23):8167-8178. PubMed ID: 34031671
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of stable platinum complexes containing carborane in a carrier group for potential BNCT agents.
Yoo J; Do Y
Dalton Trans; 2009 Jul; (25):4978-86. PubMed ID: 19662290
[TBL] [Abstract][Full Text] [Related]
15. May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs?
Ravera M; Gabano E; Tinello S; Zanellato I; Osella D
J Inorg Biochem; 2017 Feb; 167():27-35. PubMed ID: 27898344
[TBL] [Abstract][Full Text] [Related]
16. A computational mechanistic investigation into the reduction of Pt(iv) prodrugs with two axial chlorides by biological reductants.
Ejehi Z; Ariafard A
Chem Commun (Camb); 2017 Jan; 53(8):1413-1416. PubMed ID: 28079213
[TBL] [Abstract][Full Text] [Related]
17. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.
Babu T; Sarkar A; Karmakar S; Schmidt C; Gibson D
Inorg Chem; 2020 Apr; 59(7):5182-5193. PubMed ID: 32207294
[TBL] [Abstract][Full Text] [Related]
18. Thermoresponsive carboplatin-releasing prodrugs.
McAdam AD; Batchelor LK; Romano-deGea J; Vasilyev D; Dyson PJ
J Inorg Biochem; 2024 May; 254():112505. PubMed ID: 38377623
[TBL] [Abstract][Full Text] [Related]
19. Extended X-ray absorption fine structure study on reaction of anti-tumor platinum complexes with reduced glutathione.
Obata M; Harada M; Ohi H; Hirohara S; Gottchaldt M; Yano S
Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1107-9. PubMed ID: 19801867
[TBL] [Abstract][Full Text] [Related]
20. Pt(IV) complexes as prodrugs for cisplatin.
Shi Y; Liu SA; Kerwood DJ; Goodisman J; Dabrowiak JC
J Inorg Biochem; 2012 Feb; 107(1):6-14. PubMed ID: 22169035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
